tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Keros Therapeutics Reports Strong Revenue Growth
PremiumCompany AnnouncementsKeros Therapeutics Reports Strong Revenue Growth
16d ago
Strategic Focus on KER-065 and Leadership Changes Justify Buy Rating for Keros Therapeutics
Premium
Ratings
Strategic Focus on KER-065 and Leadership Changes Justify Buy Rating for Keros Therapeutics
21d ago
Keros Therapeutics’ Workforce Cuts: Potential Savings vs. Strategic Risks
Premium
Company Announcements
Keros Therapeutics’ Workforce Cuts: Potential Savings vs. Strategic Risks
21d ago
Keros Therapeutics Announces Strategic Realignment and Leadership Changes
PremiumCompany AnnouncementsKeros Therapeutics Announces Strategic Realignment and Leadership Changes
23d ago
Keros Therapeutics reports Q2 EPS (76c), consensus ($1.13)
Premium
The Fly
Keros Therapeutics reports Q2 EPS (76c), consensus ($1.13)
23d ago
Keros Therapeutics Begins Phase 3 Trial for Elritercept
Premium
Company Announcements
Keros Therapeutics Begins Phase 3 Trial for Elritercept
1M ago
Keros Therapeutics downgraded to Neutral from Buy at BofA
PremiumThe FlyKeros Therapeutics downgraded to Neutral from Buy at BofA
3M ago
ADAR1 says Keros needs ‘fresh perspectives in the boardroom’
Premium
The Fly
ADAR1 says Keros needs ‘fresh perspectives in the boardroom’
3M ago
Keros Therapeutics Concludes Strategic Alternatives Review
Premium
Company Announcements
Keros Therapeutics Concludes Strategic Alternatives Review
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100